MyFinsight
Home
Blog
About
Contact
Download
Download image
Change in fair value of
warrant liabilities
-$8,199K
Interest income
$3,915K
Grant income
$89K
Net loss and
comprehensive loss
-$38,182K
Total other income
(expense), net
$10,084K
Interest expense
$2,119K
Loss from operations
-$48,266K
Total operating
expenses
$48,266K
Research and development
$30,496K
General and
administrative
$17,770K
Back
Back
Income Statement
source: myfinsight.com
Candel Therapeutics, Inc. (CADL)
Candel Therapeutics, Inc. (CADL)